SCHEMBL5236509

SCHEMBL5236509

CCCCOC(=O)Nc1cnc(C(C)(C)C)nc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
CYP1A2 P05177 3/20 0.50
CYP2C19 P33261 3/20 0.50
ALDH1A1 P00352 7/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
HPGD P15428 4/20 0.47
KDM4E B2RXH2 2/20 0.47
RAB9A P51151 7/20 0.46
NPC1 O15118 6/20 0.46
CASP1 P29466 1/20 0.46
TSHR P16473 4/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP2C9 P11712 1/20 0.40
MAPT P10636 2/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 1/20 0.39
NFKB1 P19838 1/20 0.39
STAT1 P42224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2159197 0.80 ATR (0.42) NPSR1NFKB1NFKB2RELA
SCHEMBL29028879 0.74 HPGD (0.49) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL2159167 0.71 NPSR1 (0.42) SMN1; SMN2ALDH1A1L3MBTL1KDM4ENPSR1
SCHEMBL13456099 0.69 MAPK14 (0.57) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL2158565 0.69 NPSR1 (0.42) SMN1; SMN2ALDH1A1L3MBTL1HPGDKDM4E
SCHEMBL6100318 0.67 RAB9A (0.65) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL994563 0.66 RAB9A (0.55) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL6256084 0.65 RAB9A (0.52) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL15552811 0.65 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL4779529 0.65 ALDH1A1 (0.60) SMN1; SMN2CYP1A2CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656138-A4 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2007-04-18 EP disclosed
EP-1656138-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005020899-A2 SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed